Barcelona snapshots

Prof. Mara Parellada

Mara Parellada psychiatrist Controversias Psiquiatry Barcelona
University of California San Francisco, USA & Universidad Complutense de Madrid, Spain
Talk Violence/aggression in neurodevelopmental disorders
Date Friday, May 15th, 2020
Time 9:15 to 10:00
Round Table Violence and aggression in the psychiatric ground

BIOGRAPHY

Dr Parellada received her medical degree from the University Autonoma (Madrid), her Psychiatry Specialty from the University Complutense, and her Specialization in Child and Adolescent Psychiatry from the Institute of Psychiatry, London. Her PhD in Medicine (European Doctorate) was conducted in the University of Alcalá.

She joined the Department of Psychiatry, University Complutense, Madrid, as Assistant Professor, in 2008 and she joined the faculty of the Department of Psychiatry, University of California in San Francisco (UCSF) as Adjunct Professor in 2015.

She has been consultant psychiatrist at the Department of Child and Adolescent Psychiatrist, University Hospital Gregorio Marañón (HGUGM) since 2000 and Head of the Specialty Care Programme for autism spectrum disorders (ASD), recognized as Best Practices Programme by the Spanish Health System since 2009 and Head of the Complex Diagnosis Unit since 2016. Both clinical programmes are based in the HGUGM and have a catchment population of 6.000,000 (whole Region of Madrid). She co-authored www.doctortea.org, a web for the desensitization for medical environment in ASD. Clinically, in addition to treating patients with ASD, she has focused on the improvement of services for this population within the public health system.

She has served as the principal investigator in autism for the HGUGM since 2007 and the HGUGM site within the Spanish Biomedical Research Center for Mental Health Network (CIBERSAM), studying, mainly, the neurobiology of ASD, the overlap between ASD and psychotic disorders and the identification of distinct biotypes withinof ASD. Recently, she started leading the conduct of clinical trials for the core symptoms of ASD in Spain and is principal investigator of a multi-site clinical trial funded by Horizon 2020. She has received multiple research grants in competitive calls and her research has been funded by both public and private institutions.

She has published multiple scientific articles in international peer-review journals in the field of neurodevelopmental disorders (https://scholar.google.es/citations?user=gbuSdmkAAAAJ), and has contributed to multiple national and international conferences.

ABSTRACT

REFERENCES